![Patricia Hurter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patricia Hurter
Directeur/Membre du Conseil chez
The Harvard Conservation Trust
Profil
Patricia N.
Hurter is currently the Director at Lyndra Therapeutics, Inc. and a Trustee at The Harvard Conservation Trust.
Previously, she held positions as the Director of Formulation Design & Characterization at Merck & Co., Inc., an Independent Director at Synlogic, Inc., and the Senior Vice President at Vertex Pharmaceuticals, Inc. She has an undergraduate degree from the University of KwaZulu-Natal, a doctorate degree from the Massachusetts Institute of Technology, and a graduate degree from West Virginia University.
Postes actifs de Patricia Hurter
| Sociétés | Poste | Début |
|---|---|---|
The Harvard Conservation Trust | Directeur/Membre du Conseil | - |
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform | Directeur/Membre du Conseil | - |
Anciens postes connus de Patricia Hurter
| Sociétés | Poste | Fin |
|---|---|---|
| SYNLOGIC, INC. | Directeur/Membre du Conseil | 20/03/2024 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/01/2019 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de Patricia Hurter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
University of KwaZulu-Natal
 University of KwaZulu-Natal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
West Virginia University
 West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform | Technology Services |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
The Harvard Conservation Trust |
